Adma Biologics (ADMA) Other Working Capital Changes (2011 - 2025)
Adma Biologics (ADMA) posted Other Working Capital Changes of $547000.0 for Q4 2025, up 148.97% on a QoQ basis from -$1.1 million in Q3 2025, and up 136.08% year-over-year from $231699.4 in Q4 2024.
Adma Biologics (ADMA) Other Working Capital Changes (2011 - 2025) Analysis & Trends
Adma Biologics' Other Working Capital Changes history runs 12 years deep, the most recent figure standing at $547000.0 for Q4 2025.
- Quarterly Other Working Capital Changes rose 136.08% year-over-year to $547000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.5 million (down 43.41% YoY) and the FY2025 annual result came in at $1.5 million, down 43.41% from the prior year.
- Other Working Capital Changes was $547000.0 for Q4 2025 at Adma Biologics, up from -$1.1 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $4.0 million in Q3 2024 and bottomed at -$1.6 million in Q1 2024.
- A 5-year average of $325400.0 and a median of -$64095.0 in 2021 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 3690.18% in 2024, while the deepest fall reached 767.84% in 2024.
- Adma Biologics' Other Working Capital Changes stood at -$1.5 million in 2021, then surged by 81.76% to -$277238.0 in 2022, then surged by 181.88% to $227000.0 in 2023, then sank by 767.84% to -$1.5 million in 2024, then soared by 136.08% to $547000.0 in 2025.
- Business Quant data shows ADMA's Other Working Capital Changes at $547000.0 in Q4 2025, -$1.1 million in Q3 2025, and -$501000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 547,000.00 |
| Dec 31, 2025 | 547,000.00 |
| Dec 31, 2025 | 547,000.00 |
| Sep 30, 2025 | -1.12 Mn |
| Sep 30, 2025 | -1.12 Mn |
| Sep 30, 2025 | -1.12 Mn |
| Jun 30, 2025 | -501,000.00 |
| Jun 30, 2025 | -501,000.00 |
| Jun 30, 2025 | -501,000.00 |
| Mar 31, 2025 | 2.60 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Sep 30, 2024 | 4.02 Mn |
| Sep 30, 2024 | 4.02 Mn |
| Sep 30, 2024 | 4.02 Mn |
| Jun 30, 2024 | 1.78 Mn |
| Jun 30, 2024 | 1.78 Mn |